Skip to main content
main-content

Brain metastases in NSCLC

Videos

18-06-2019 | CNS metastases | Video | Article

Managing brain metastases in lung cancer

Brain metastases are a common complication of lung cancer and are associated with significant morbidity and mortality. In these videos, Manmeet Ahluwalia provides a neuro-oncologist's perspective on managing lung cancer patients who develop these metastases.

This content collection was made possible by independent educational funding provided by AstraZeneca.

Downloadable slide set

18-09-2019 | Article

Brain metastases in lung cancer: Key abstracts from the 2019 ASCO Annual Meeting

Here we provide digestible and downloadable summaries of the key studies presented at the ASCO Annual Meeting 2019 as a resource for HCPs managing NSCLC patients with BMs.

This content collection was made possible by independent educational funding provided by AstraZeneca.

Key journal articles

21-08-2019 | Review | Article

Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion

Preusser M et al. ESMO Open 2018; 3(1): e000262. doi:10.1136/esmoopen-2017-000262. eCollection 2018

21-08-2019 | Review | Article

Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors

Wrona A et al. Cancer Treat Rev 2018; 71: 59–67. doi:10.1016/j.ctrv.2018.10.011.

22-08-2019 | Review | Article

Risk factors for brain metastases in patients with non–small‐cell lung cancer

An N et al. Cancer Med 2018; 7(12): 6357-6364. doi:10.1002/cam4.1865

22-08-2019 | Article

Epidermal growth factor receptor mutational status and brain metastases in non-small-cell lung cancer

Bhatt VR et al. J Glob Oncol 2016; 3(3): 208–217. doi:10.1200/JGO.2016.00339

22-08-2019 | Article

CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource Utilization

Chooback N, Lefresne S, Lau SC, Ho C. J Oncol Pract 2018; 14(10): e612–e620. doi:10.1200/JOP.18.00054

22-08-2019 | Article

McGranahan T, Nagpal S. Curr Treat Options Oncol 2017; 18(4): 22. doi:10.1007/s11864-017-0466-0

McGranahan T, Nagpal S. Curr Treat Options Oncol 2017; 18(4): 22. doi:10.1007/s11864-017-0466-0

22-08-2019 | Article

Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer

Kakusa B et al. J Neurooncol 2018; 140(3): 705–715. doi:10.1007/s11060-018-03002-0


Funding
 

This content collection was made possible by independent educational funding provided by AstraZeneca.

Image Credits